N
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A343.2 KBNGM BIOPHARMACEUTICALS INCApr 5, 10:55 AM ET·0000950142-24-000985
- 8-K272.5 KBNGM BIOPHARMACEUTICALS INCApr 5, 10:10 AM ET·0001193125-24-088076
- 10-K/A760.3 KBNGM BIOPHARMACEUTICALS INCApr 4, 4:42 PM ET·0001628280-24-014888
- 10-K9.6 MBNGM BIOPHARMACEUTICALS INCMar 11, 4:15 PM ET·0001628280-24-010232
- 8-K298.0 KBNGM BIOPHARMACEUTICALS INCMar 11, 4:13 PM ET·0001628280-24-010229
- SC 13D/A1.0 MBNGM BIOPHARMACEUTICALS INCFeb 26, 5:16 PM ET·0000950142-24-000549
- 8-K882.0 KBNGM BIOPHARMACEUTICALS INCFeb 26, 5:01 PM ET·0001193125-24-046296
- SC 13G/A47.2 KBNGM BIOPHARMACEUTICALS INCFeb 14, 6:12 PM ET·0000935836-24-000216
- SC 13G/A13.1 KBNGM BIOPHARMACEUTICALS INCFeb 13, 5:09 PM ET·0001104659-24-021563
- 8-K140.0 KBNGM BIOPHARMACEUTICALS INCJan 22, 6:09 AM ET·0001193125-24-011619
Insiders
10- CHEN JIN-LONGDirector, Chief Scientific Officer
- COLUMN GROUP GP, LP10% Owner
- Column Group II GP, LP10% Owner, General Partner
- COLUMN GROUP III-A, LP10% Owner
- COLUMN GROUP III GP, LP10% Owner, General Partner
- COLUMN GROUP III, LP10% Owner
- COLUMN GROUP II, LP10% Owner
- Column Group IV-A, LP10% Owner
- COLUMN GROUP L P10% Owner
- GOEDDEL DAVID VDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA, 94080
mailing
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA, 94080